Quality of life and cholinesterase inhibitors: A qualitative study of patients with Alzheimer's Disease and their carers

Australasian Psychiatry

Volumn 16, Issue 6, 2008, Pages 433-437

  Smith, Bethany ^a   Chur Hansen, Anna ^a   Neale, Alice ^a   Symon, Jonathon ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Alzheimer's disease; Carer; Cholinesterase inhibitors; Qualitative; Quality of life

Indexed keywords

CHOLINESTERASE INHIBITOR;

AGED; ALZHEIMER DISEASE; ARTICLE; CAREGIVER SUPPORT; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DRUG EFFICACY; EMOTIONAL STABILITY; FEMALE; FUNCTIONAL STATUS; GERONTOPSYCHIATRY; HOPELESSNESS; HUMAN; LONG TERM MEMORY; MALE; MENTAL DETERIORATION; QUALITATIVE RESEARCH; QUALITY OF LIFE; SHORT TERM MEMORY; THEMATIC ANALYSIS;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CAREGIVERS; CHOLINESTERASE INHIBITORS; COST OF ILLNESS; EMOTIONS; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MENTAL RECALL; MOTIVATION; PATIENT SATISFACTION; PRODUCT SURVEILLANCE, POSTMARKETING; QUALITY OF LIFE; SOUTH AUSTRALIA; TREATMENT OUTCOME;

EID: 56749169624     PISSN: 10398562     EISSN: 14401665     Source Type: Journal    
DOI: 10.1080/10398560802375990     Document Type: Article

References (21)

1. AIHW
2. AD2000 Collaborative Group (2004) Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): Randomised double-blind trial. The Lancet, pp. 2105-2115.
3. Grimley Evans, J, Wilcock, G. and Birks, J. (2004) Evidence-based pharmacotherapy of Alzheimer's disease. International Journal of Neuropsychopharmacology, 7, pp. 351-369.
4. Wilcock, G., Howe, I. Coles, H. et al. (2003) A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease. Drugs and Aging, 20, pp. 777-789.
5. Farlow, M. (2002) Do cholinesterase inhibitors slow the progression of Alzheimer's disease?. International Journal of Clinical Practice, 127, pp. 37-44.
6. Inglis, F. (2002) The tolerability and safety of cholinesterase inhibitors in the treatment of dementia. International Journal of Clinical Practice, 127, pp. 45-63.
7. Poirier, J. (2002) Evidence that the clinical effects of cholinesterase inhibitors are related to potency and targeting of action. International Journal of Clinical Practice, 127, pp. 6-19.
8. Rosler, M. (2002) The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia. International Journal of Clinical Practice, 127, pp. 20-36.
9. Lyketsos, C., Reichman, W., Kershaw, P. and Zhu, Y. (2004) Long-term outcomes of galantamine treatment in patients with Alzheimer's disease. American Journal of Geriatric Psychiatry, 12, pp. 473-482.
10. Ritchie, C., Ames, D., Clayton, T. and Lai, R. (2004) Meta-analysis of randomised trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease. American Journal of Geriatric Psychiatry, 12, pp. 358-369.
11. Langdon, S., Eagle, A. and Warner, J. (2007) Making sense of dementia in the social world: A qualitative study. Social Science and Medicine, 64, pp. 989-1000.
12. Kaufer, D., Borson, S., Kershaw, P. and Sadik, K. (2005) Reduction of care-giver burden in Alzheimer's disease by treatment with Galantamine. CNS Spectrums, 10, pp. 481-488.
13. Huizing, A., Berghmans, R., Widdershoven, G. and Verhey, F. (2006) Do caregivers' experiences correspond with the concerns raised in the literature? Ethical issues relating to anti-dementia drugs. International Journal of Geriatric Psychiatry, 21, pp. 869-875.
14. Aggarwal, N., Vass, AA, Minardi, HA, Ward, R., Garfield, C. and Cybyr, B. (2003) People with dementia and their relatives: Personal experiences of Alzheimer's and of the provision of care. Journal of Psychiatric and Mental Health Nursing, 10, pp. 187-197.
15. Brodaty, H. and Green, A. (2002) Who cares for the carers? The often forgotten patient. Australian Family Physician, 31, pp. 833-836.
16. Millan-Calenti, JC, Gandoy-Crego, M. Antelo-Martelo, M. et al. (2000) Helping the family carers of Alzheimer's patients: From theory...to practice. A preliminary study. Archives of Gerontology and Geriatrics, 30, pp. 131-138.
17. Pope, C. and Mays, N. (2006) Qualitative Research in Health Care, BMJ Books, London
18. Lanctot, K., Herrmann, N. Yau, KK. et al. (2003) Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: A meta-analysis. Canadian Medical Association Journal, 16, pp. 557-564.
19. Francis, P., Nordberg, A. and Arnold, S. (2005) A preclinical view of cholinesterase inhibitors in neuroprotection: Do they provide more than symptomatic benefits in Alzheimer's disease?. Trends in Pharmacological Sciences, 26, pp. 104-111.
20. Borbasi, S., Jones, J., Lockwood, C. and Emden, C. (2006) Health professionals' perspectives of providing care to people with dementia in the acute setting: Toward better practice. Geriatric Nursing, 27, pp. 300-307.
21. Volicer, L. and Ganzini, L. (2003) Health professionals' views on standards for decision-making capacity regarding refusal of medical treatment in mild Alzheimer's disease. Journal of the American Geriatric Society, 51, p. 127.